Cargando…

Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling

Procollagen lysyl hydroxylase 1 (PLOD1) is highly expressed in malignant tumors such as esophageal squamous cell carcinoma, gastric cancer, and colorectal cancer. Bioinformatics analysis revealed that PLOD1 is associated with the progression of GBM, particularly the most malignant mesenchymal subtyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhenlin, Shi, Yuping, Ying, Chenting, Jiang, Yang, Hu, Jiangfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906902/ https://www.ncbi.nlm.nih.gov/pubmed/33420370 http://dx.doi.org/10.1038/s41388-020-01635-y

Ejemplares similares

PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022)

COLGALT2 is overexpressed in ovarian cancer and interacts with PLOD3
por: Guo, Ting, et al.
Publicado: (2021)

Expression and Prognostic Role of PLOD1 in Malignant Glioma
por: Wang, Hao, et al.
Publicado: (2020)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Overexpressing PLOD family genes predict poor prognosis in gastric cancer
por: Li, Shan-Shan, et al.
Publicado: (2020)

Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer
por: Zhang, Jing, et al.
Publicado: (2022)

NEK2 enhances malignancies of glioblastoma via NIK/NF-κB pathway
por: Xiang, Jianyang, et al.
Publicado: (2022)

PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression
por: Kreße, Nina, et al.
Publicado: (2022)

Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma
por: Song, Ye, et al.
Publicado: (2017)

HCK promotes glioblastoma progression by TGFβ signaling
por: Wang, Zhenlin, et al.
Publicado: (2020)

IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance
por: Rinkenbaugh, Amanda L., et al.
Publicado: (2016)

PLOD3 promotes lung metastasis via regulation of STAT3
por: Baek, Jeong-Hwa, et al.
Publicado: (2018)

Hypoxia Induced NF-κB
por: D’Ignazio, Laura, et al.
Publicado: (2016)

NF-κB Signalling in Glioblastoma
por: Soubannier, Vincent, et al.
Publicado: (2017)

Roles of PLODs in Collagen Synthesis and Cancer Progression
por: Qi, Yifei, et al.
Publicado: (2018)

Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation
por: Liu, Tao, et al.
Publicado: (2023)

NF-κB, Mesenchymal Differentiation and Glioblastoma
por: Yamini, Bakhtiar
Publicado: (2018)

Overexpressed MPS-1 contributes to endometrioma development through the NF-κB signaling pathway
por: Liu, Yang, et al.
Publicado: (2021)

Characterisation of the Drosophila procollagen lysyl hydroxylase, dPlod
por: Bunt, Stephanie, et al.
Publicado: (2011)

PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics
por: Sheng, Xiaoli, et al.
Publicado: (2019)

Chronic Inflammation Pathway NF-κB Cooperates with Epigenetic Reprogramming to Drive the Malignant Progression of Glioblastoma
por: Lin, Kefeng, et al.
Publicado: (2022)

Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma
por: Flor, Susanne, et al.
Publicado: (2021)

NF-κB in Hematological Malignancies
por: Imbert, Véronique, et al.
Publicado: (2017)

Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma
por: Li, Keren, et al.
Publicado: (2023)

NF-κB inhibitor with Temozolomide results in significant apoptosis in glioblastoma via the NF-κB(p65) and actin cytoskeleton regulatory pathways
por: Avci, Naze G., et al.
Publicado: (2020)

Clinical Prognostic Value of the PLOD Gene Family in Lung Adenocarcinoma
por: Meng, Yiming, et al.
Publicado: (2022)

Induction of Peroxiredoxin 1 by Hypoxia Regulates Heme Oxygenase-1 via NF-κB in Oral Cancer
por: Zhang, Min, et al.
Publicado: (2014)

Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB
por: D’Ignazio, Laura, et al.
Publicado: (2017)

RSL3 Drives Ferroptosis through NF-κB Pathway Activation and GPX4 Depletion in Glioblastoma
por: Li, Shengbiao, et al.
Publicado: (2021)

PRAJA is overexpressed in glioblastoma and contributes to neural precursor development
por: Shin, Joshua, et al.
Publicado: (2017)

PRAJA is overexpressed in glioblastoma and contributes to neural precursor development
por: Shin, Joshua, et al.
Publicado: (2017)

The NFκB pathway: a therapeutic target in glioblastoma
por: Nogueira, Lorena, et al.
Publicado: (2011)

Targeting NF-κB in glioblastoma: A therapeutic approach
por: Friedmann-Morvinski, Dinorah, et al.
Publicado: (2016)

PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC
por: Du, Hongzhi, et al.
Publicado: (2017)

Rhein inhibits malignant phenotypes of human renal cell carcinoma by impacting on MAPK/NF-κB signaling pathways
por: Ma, Ya-Li, et al.
Publicado: (2018)

Cerebral small vessel disease caused by PLOD3 mutation: Expanding the phenotypic spectrum of lysyl hydroxylase‐3 deficiency
por: Zhou, Ji, et al.
Publicado: (2022)

Hypoxia-Induced ROS Contribute to Myoblast Pyroptosis during Obstructive Sleep Apnea via the NF-κB/HIF-1α Signaling Pathway
por: Yu, Li-Ming, et al.
Publicado: (2019)

PLOD3 contributes to HER-2 therapy resistance in gastric cancer through FoxO3/Survivin pathway
por: Chen, Yueda, et al.
Publicado: (2022)

Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling
por: Jiang, Lili, et al.
Publicado: (2019)

Hypoxia induced LBH overexpression accelerates malignant progression in glioma
por: Zhang, Ke-Nan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_btva1fflkj7evgp7gajg7nc2fr